Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GHSR | Q92847 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.33 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.32 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10040060 | 1.00 | KMT2A (0.38) | KMT2AALDH1A1MEN1TSHRMAPK1 | |
| SCHEMBL13525930 | 1.00 | KMT2A (0.38) | KMT2AALDH1A1MEN1TSHRMAPK1 | |
| SCHEMBL25492214 | 0.89 | KMT2A (0.38) | KMT2AALDH1A1MEN1TSHRMAPK1 | |
| SCHEMBL4434237 | 0.89 | KMT2A (0.38) | KMT2AALDH1A1MEN1TSHRMAPK1 | |
| SCHEMBL15826780 | 0.88 | KMT2A (0.38) | KMT2AALDH1A1MEN1TSHRMAPK1 | |
| SCHEMBL15306516 | 0.88 | KMT2A (0.38) | KMT2AALDH1A1MEN1TSHRMAPK1 | |
| SCHEMBL6886075 | 0.88 | KMT2A (0.38) | KMT2AALDH1A1MEN1TSHRMAPK1 | |
| SCHEMBL15257504 | 0.88 | KMT2A (0.38) | KMT2AALDH1A1MEN1TSHRMAPK1 | |
| SCHEMBL12173239 | 0.88 | KMT2A (0.38) | KMT2AALDH1A1MEN1TSHRMAPK1 | |
| SCHEMBL2362032 | 0.88 | KMT2A (0.38) | KMT2AALDH1A1MEN1TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119823001-A | Urea compounds antagonizing LPA1 receptor | 大正制药株式会社 | 2025-04-15 | — | — | CN | disclosed |
| CN-114206832-B | Urea compounds antagonizing LPA1 receptor | 大正制药株式会社 | 2025-04-04 | — | — | CN | disclosed |
| EP-3354639-B1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2024-02-21 | — | — | EP | disclosed |
| EP-3530648-B1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2023-11-08 | — | — | EP | disclosed |
| CN-114206832-A | Urea compounds antagonizing LPA1 receptor | 大正制药株式会社 | 2022-03-18 | — | — | CN | disclosed |
| EP-3950673-A1 | INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF | Inspirna, Inc. (US) | 2022-02-09 | — | — | EP | disclosed |
| US-20210386873-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDIPHYSICS CO LTD (JP) | 2021-12-16 | — | — | US | disclosed |
| US-11083804-B2 | Precursor compound of radioactive halogen-labeled organic compound | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2021-08-10 | — | — | US | disclosed |
| US-10953112-B2 | Precursor compound of radioactive halogen-labeled organic compound | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2021-03-23 | — | — | US | disclosed |
| US-20200282082-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2020-09-10 | — | — | US | disclosed |
| US-7897811-B2 | Process for production of radioactive fluorine-labeled organic compound | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2011-03-01 | — | — | US | disclosed |
| US-20100261931-A1 | PROCESS FOR PRODUCTION OF RADIOACTIVE-FLUORINE-LABELED ORGANIC COMPOUND | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-10-14 | — | — | US | disclosed |
| EP-2230229-A1 | PROCESS FOR PRODUCTION OF RADIOACTIVE-FLUORINE-LABELED ORGANIC COMPOUND | Nihon Medi-Physics Co., Ltd. (JP) | 2010-09-22 | — | — | EP | disclosed |
| WO-2010070615-A1 | CYSTEINE PROTEASE INHIBITORS | MEDIVIR UK LTD (GB) | 2010-06-24 | — | — | WO | disclosed |
| US-20100016626-A1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2010-01-21 | — | — | US | disclosed |
| EP-2128130-A1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | Nihon Medi-Physics Co., Ltd. (JP) | 2009-12-02 | — | — | EP | disclosed |
| US-20090198085-A1 | Process for Production of Radioactive Fluorine-Labeled Organic Compound | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2009-08-06 | — | — | US | disclosed |
| EP-2017258-A1 | PROCESS FOR PRODUCTION OF RADIOACTIVE FLUORINE-LABELED ORGANIC COMPOUND | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2009-01-21 | — | — | EP | disclosed |
| US-20080281121-A1 | Precursor Compound of Radioactive Halogen-Labeled Organic Compound | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2008-11-13 | — | — | US | disclosed |
| EP-1978015-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN LABELED ORGANIC COMPOUND | NIHON MEDI-PHYSICS CO., LTD. (JP) | 2008-10-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11083804-B2 | Precursor compound of radioactive halogen-labeled organic compound | BCAT2, SLCO2B1, ORC3 | KMT2A 3576/4885ALDH1A1 2188/4885MEN1 3670/4885 |
| US-20210386873-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | BCAT2, SLCO2B1, ORC3 | KMT2A 3576/4885ALDH1A1 2188/4885MEN1 3670/4885 |
| US-20100016626-A1 | PROCESS FOR PRODUCTION OF PRECURSOR COMPOUND FOR RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | FUS, SLC43A1, PFAS | KMT2A 3174/4885ALDH1A1 3514/4885MEN1 1351/4885 |
| US-20090198085-A1 | Process for Production of Radioactive Fluorine-Labeled Organic Compound | FOSB, AFF1, SLCO4C1 | KMT2A 1919/4885ALDH1A1 1287/4885MEN1 797/4885 |
| US-20100261931-A1 | PROCESS FOR PRODUCTION OF RADIOACTIVE-FLUORINE-LABELED ORGANIC COMPOUND | AFF1, SLCO4C1, SLCO2A1 | KMT2A 2150/4885ALDH1A1 673/4885MEN1 793/4885 |
| US-20080281121-A1 | Precursor Compound of Radioactive Halogen-Labeled Organic Compound | BCAT2, SLCO2B1, ORC3 | KMT2A 3576/4885ALDH1A1 2188/4885MEN1 3670/4885 |
| US-20200282082-A1 | PRECURSOR COMPOUND OF RADIOACTIVE HALOGEN-LABELED ORGANIC COMPOUND | BCAT2, SLCO2B1, ORC3 | KMT2A 3576/4885ALDH1A1 2188/4885MEN1 3670/4885 |
| US-10953112-B2 | Precursor compound of radioactive halogen-labeled organic compound | BCAT2, SLCO2B1, ORC3 | KMT2A 3576/4885ALDH1A1 2188/4885MEN1 3670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.